knowledge -WSS

knowledge

author：focus 2025-10-01 18:08:04 - browse：9184

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Ethical issues complicate the benefits of medical crowdfunding

hotspot

knowledge

WSS

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

'Make People Better': The CRISPR babies story you probably don't know

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Covid hospitalizations on the rise, Humana says

Why Novartis is changing the name of its research labs

In early work, researchers turn to CRISPR to treat Alzheimer's

focus

knowledge

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The 10 drugs up first for Medicare price negotiation

Anesthesiologist group: stop taking Ozempic before surgery

Medicaid rebukes states for mistakenly disenrolling children

In Memoriam: Notable people who died in 2023

How Medicaid coverage policies for immigrants impact new moms

Peter Hotez and the public health issue of online harassment

Listen: Biogen's potential pivot, & Illumina's next chapter

In age of alternative facts, a scholarly course on calling out crap

STAT Virtual Event: The State of Biosimilars: What to Watch

focus

A public scorecard can help hold safety

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

How to fix cancer clinical trials' diversity problem

As digital health tech proliferates, a new institute aims to cut through hype

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Covid hospitalizations on the rise, Humana says

explore

hotspot

knowledge

focus